Press release
Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028
This research assessment managed by FactMR works to highlight the expected transformations that will occur in the “Hyperemesis Gravidarum Treatment Market” market in the coming years. FactMR has worked diligently to compile primary market facets through this report titled “Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028” which will soon be published for benefitting the readers. The availability of crucial statistics such as market revenue, market size, Y-o-Y growth, regional market share etc., will be included in the assessment for gaining better insight about the “Hyperemesis Gravidarum Treatment Market” market during the forecast period.Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2183
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price of drugs may hinder the growth of the hyperemesis gravidarum treatment market.
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and anti-hitamines medications. Sometimes, in case of hospitalization intravenous fluid is given to the mother to restore the electrolyte balance, nutrients, and vitamins. Hyperemesis gravidarum treatment depends on the severity of symptoms in patients. Hyperemesis gravidarum needs to be diagnosed as early as possible to reduce the risk of morbidity of both mother and foetus.
As per a recent literature survey conducted by the State University of New York (SUNY) reveals that approximately 0.3 to 3% of pregnancy cases need hyperemesis gravidarum treatment.
To know more about the Hyperemesis Gravidarum Treatment Market Visit the link- https://www.factmr.com/report/2183/hyperemesis-gravidarum-treatment-market
Hyperemesis Gravidarum Treatment Market: Overview
The dietary supplements and anti-emetic medications are expected to generate significant revenue over the forecast in the global hyperemesis gravidarum treatment market, followed by prokinetic agents. People prefer OTC products rather than prescription drugs for hyperemesis gravidarum treatment, which is expected to drive the growth of the retail segment over the forecast period. Based on RoA, intravenous treatment is gaining popularity for hyperemesis gravidarum treatment because in this way the drugs directly get absorbed into the blood-stream, leaving no option to irritate the gastric mucosa. Some of the popular brands of hyperemesis gravidarum treatment include Diclectin (Duchesnay Inc.), Pregvit (Duchesnay Inc.), Zofran (Novartis AG), Zuplenz (Midatech Pharma US Inc.), Kytril (Genentech, Inc.), etc.
Hyperemesis Gravidarum Treatment Market: Regional Outlook
Geographically, the global hyperemesis gravidarum treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is expected to be the dominant regional market for hyperemesis gravidarum treatment due to the growing awareness regarding use of prescription drugs. Europe is expected to contribute second large revenue share in the global hyperemesis gravidarum treatment market throughout the forecast period due increasing number of patients with need of hyperemesis gravidarum treatment. With increase in the expenditure for healthcare sector and growing awareness regarding hyperemesis gravidarum treatment among general population, the hyperemesis gravidarum treatment market is expected to grow at a significant CAGR in Asia Pacific.
Hyperemesis Gravidarum Treatment: Key Players
The global Hyperemesis Gravidarum Treatment is highly fragmented with a large number of global players operating. Examples of some of the key players identified in the global hyperemesis gravidarum treatment market are Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., and Genentech, Inc., among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2183
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028 here
News-ID: 1653683 • Views: …
More Releases from Fact.MR

Recycled Paper Bags Market is Expected to Reach a Valuation of USD 7 billion by …
The global recycled paper bags market is poised for steady expansion in the coming decade. As of 2025, the market is estimated at USD 5 billion, and projections indicate it will increase to approximately USD 7 billion by 2035, achieving a compound annual growth rate (CAGR) of 3.4 percent over this period. This growth is fuelled by increasing regulatory pressure on single-use plastics, rising consumer preference for sustainable packaging, and…
Himalayan Salt Market is Expected to Reach a Valuation of USD 868.3 million by 2 …
The Himalayan salt market has been experiencing consistent growth, fueled by rising consumer awareness of natural and wellness-oriented products. Market projections indicate that the global Himalayan salt industry will expand from USD 528 million in 2025 to USD 868.3 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.1 percent. This growth is not only tied to the increasing popularity of Himalayan salt as a culinary ingredient but…

Tinplate Market is Expected to Reach a Valuation of USD 35.4 billion by 2035 | F …
The global tinplate market is projected to increase from USD 25.8 billion in 2025 to USD 35.4 billion by 2035, registering a compound annual growth rate (CAGR) of 3.2 percent during the forecast period. This growth is being driven by a rising emphasis on sustainable, recyclable packaging solutions, alongside the strong performance of the food and beverage industry. Tinplate is increasingly favored due to its durability, corrosion resistance, and recyclability,…

Sulphur-Coated Urea Market is Expected to Reach a Valuation of USD 7.5 billion b …
The global sulphur-coated urea market is entering a phase of robust expansion. The market is expected to rise from USD 4.0 billion in 2025 to USD 7.5 billion by 2035, registering a compound annual growth rate (CAGR) of 6.5 percent over the forecast period. This growth highlights the increasing importance of controlled-release fertilizers in modern agriculture, where nutrient efficiency and reduced losses are becoming critical priorities.
Segmentation of the Sulphur-Coated Urea…
More Releases for Hyperemesis
Global Laboratory Information Management System Market Outlook 2022 to 2032: Gro …
Laboratory Information Management System analysis report by Fact.MR shows that global revenue of Laboratory Information Management System (LIMS) in 2021 was held at US$ 1.8 billion. With a projected CAGR of 8.1% from 2022 to 2032, the market is set to experience a growth trajectory significantly higher than its historical pace. The software segment is expected to be the highest revenue generator, creating an absolute dollar opportunity of nearly US$…
Hyperemesis Gravidarum Market Precise Scenario Covering Trends, Opportunities an …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price…
Global Hyperemesis Gravidarum Market Projections Analyzed To Inspect Growth Tren …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price…
Central Pontine Myelinolysis Market Treatment Methods Analysis 2019 with Key Pla …
The market drivers for Central Pontine Myelinolysis Market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.
Global Central Pontine Myelinolysis Market - Key players
Some of key players profiled in the report…
Central Pontine Myelinolysis Market with Major Players Like Fujifilm Holdings Co …
Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures…
Growth Predictions on Global Hyperemesis Gravidarum Treatment Market Through 202 …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and…